
中东和非洲精准诊断市场预测至 2028 年 – COVID-19 影响和区域分析 – 按类型(基因测试、深奥测试等)、应用(肿瘤学、心脏病学、呼吸系统疾病、免疫学等)和最终用户(临床实验室、医院、家庭护理等)
No. of Pages: 133 | Report Code: BMIRE00026145 | Category: Life Sciences
No. of Pages: 133 | Report Code: BMIRE00026145 | Category: Life Sciences
中东和中东地区的精准诊断市场非洲预计将从 2022 年的 31.5233 亿美元增长到 2028 年的 60.6261 亿美元。预计 2022 年至 2028 年复合年增长率为 11.5%。
精准医疗理念正在大力应用于罕见疾病的治疗。尽管它在肿瘤学中更受欢迎,但它正在逐渐传播到其他专业。癌症患病率的上升和罕见神经系统疾病发病率的增加增加了对精准医疗的需求,推动了精准诊断市场的增长。此外,肿瘤学和其他疾病对治疗程序的需求不断增长,导致治疗程序的采用激增。基因测试在许多医学领域都有帮助,因为它可以识别 DNA 中的突变或变异。例如,基因检测可提供有关患癌症风险的信息并诊断遗传疾病,例如脆性 X 综合征或亨廷顿舞蹈症。
根据癌症类型,基因组癌症检测有助于创建更加个性化的癌症治疗和护理计划,帮助患者和医生更好地了解诊断并揭示特定的癌症驱动因素,市场参与者鼓励从诊断一开始就进行基因组癌症检测,如此精确可以在治疗过程的早期给予药物。因此,早期诊断有助于促进疾病的早期和最佳管理。
此外,生物制药公司之间的战略合作越来越多根据特定患者的特殊需求开发有针对性的药物来治疗他们,并提供有效的治疗程序和服务,正在增加临床试验的数量。上述因素正在推动精准诊断市场的增长。
中东和中东地区到 2028 年非洲精密诊断市场收入及预测(百万美元)
中东及中东地区非洲精准诊断市场细分
中东和非洲非洲精准诊断市场按类型、应用、最终用户和国家/地区进行细分。根据类型,市场分为基因测试、深奥测试等。 2022 年,基因测试领域在市场中占据主导地位。
根据应用,市场细分为肿瘤学、心脏病学、免疫学、呼吸系统疾病等。 2022 年,肿瘤学领域在市场中占据主导地位。根据最终用户,市场分为医院、临床实验室、家庭护理等。 2022 年,临床实验室领域在市场中占据主导地位。
根据国家/地区,市场< /span>分为沙特阿拉伯、南非、阿联酋以及中东其他地区和地区。非洲。此外,沙特阿拉伯将在 2022 年主导市场。
一些主导中东和中东地区的主要参与者。非洲精准诊断市场包括 Abbott、Bayer AG、Koninklijke Philips NV、Novartis AG、QIAGEN、Quest Diagnostics Incorporated、Sanofi、Siemens Healthineers AG 和 Swiss Precision Diagnostics GmbH
Strategic insights for Middle East & Africa Precision Diagnostics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2022 | US$ 3,152.33 Million |
Market Size by 2028 | US$ 6,062.61 Million |
Global CAGR (2022 - 2028) | 11.5% |
Historical Data | 2020-2021 |
Forecast period | 2023-2028 |
Segments Covered |
By 类型
|
Regions and Countries Covered | 中东和非洲
|
Market leaders and key company profiles |
The regional scope of Middle East & Africa Precision Diagnostics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Middle East & Africa Precision Diagnostics Market is valued at US$ 3,152.33 Million in 2022, it is projected to reach US$ 6,062.61 Million by 2028.
As per our report Middle East & Africa Precision Diagnostics Market, the market size is valued at US$ 3,152.33 Million in 2022, projecting it to reach US$ 6,062.61 Million by 2028. This translates to a CAGR of approximately 11.5% during the forecast period.
The Middle East & Africa Precision Diagnostics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Precision Diagnostics Market report:
The Middle East & Africa Precision Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East & Africa Precision Diagnostics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East & Africa Precision Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.